Stay connected! Share and follow:

Leukaemia CARE Careline

We're here to talk | 24-hours a day

08088 010 444

FREE from landlines & most major mobile networks

Planned changes at Leukaemia CARE

written by

Leukaemia Care, Charity

  • LCS stack_cmyk_r

Statement by Monica Izmajlowicz, Chief Executive Officer at Leukaemia CARE

Following planning discussions ahead of the 2015/16 financial year, which starts on 1st April, Leukaemia CARE has taken the decision not to continue the role of Scottish Development Officer and consequently we will be closing our Scottish office.

The decision was reached after careful research, consideration and discussion about how we can become more cost effective by focusing our investments on our key services at our Head Office, based in Worcester. We believe we can grow our presence and awareness successfully from this one location, rather than two. Consequently, we will run all of our key support services exclusively from our Head Office based in Worcester. 

The office closure and the associated redundancy of Scottish Development Officer does not mean we are no longer offering our care and support services to patients, their carers and friends in Scotland; we will still continue to provide support to anybody in Scotland who is affected by a diagnosis of a blood cancer.

In addition, the decision is not a reflection on the great work we have achieved in Scotland over the last five years. We will still continue to have a presence in Scotland with our support groups, patient and carer conferences and we will still be available 24 hours a day on our CARE Line. Journey magazine and our Patient Journals will continue to be distributed in Scotland in the same way. We will also continue with our plans to recruit a new Trustee based in Scotland to our main board.

Leukaemia CARE is committed to working with and supporting anyone across the UK who is affected by a blood cancer, and will work to ensure that this decision does not impact on them.

These changes will come into effect from Monday 23rd March 2015 and Esther Wroughton, CARE Director at Leukaemia CARE, will oversee future development in Scotland.

If you are a patient, carer or medical professional with any questions or concerns about this change, please do not hesitate to get in touch with us. 

For more information, please email